Informazioni su questo podcast
Biotech—it's complicated.
A successful product launch requires grit, determination, and clear direction.
But let’s be real, the path to launch isn’t a straight one.
There are curves, hard turns, and dead ends.
Here’s the good news, you don’t have to navigate the complexities alone.
Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
Episodi
- From Academia to Biotech: Making the Transition into Biotech Leadership · 30 minMattia Calissano, VP Medical at SSI Strategy, discusses moving from academic research into drug development, communicating scientific evidence to investors, and adapting to the…
- When the Science Becomes a Company · 35 minSamir Ounzain, Scientific Co-Founder and CEO of HAYA Therapeutics, looks at how the founder's role changes as the science becomes a company and the team grows around it.
- Flexible Leadership in Biotech: Building Teams Around Program Needs · 31 minChris Kennedy, CEO of Pacific Genetech, examines a different approach to building leadership teams in early-stage biotech: building organizations around program needs rather than…
- Designing Studies that Work in Complex Settings · 19 minBrendan Slagle, Senior Director, Medical at SSI Strategy discusses why operational feasibility needs to be built into study design from the beginning rather than addressed later…
- Rethinking Trial Design for Rare Diseases · 37 minMarshall Summar, CEO & Founder of Uncommon Cures, discusses why many conventional trial models break down in rare disease settings, and what stronger alternatives look like in…
- Driving Global Patient Access: Managed Access as a Strategic Lever · 22 minNicky Wisener explores how emerging biotechs can think more strategically about patient access well before commercialization.
- Rare Disease Commercialization: Beyond Approval · 32 minMatt Trudeau discusses what it means to operate within a family-run pharmaceutical company and how that model shapes decision-making differently than a public or venture-backed…
- Clinical Operations as a Strategic Function · 21 minMeaghan Powers, Senior Director of Clinical Operations at SSI Strategy, offers a clear view of where clinical operations drives strategic value and how early engagement can set…
- How Clinical Operations Shapes Biotech Strategy · 46 minSharon Arnold, a seasoned clinical operations executive with more than two decades of experience in both large pharma and emerging biotechs, speaks about how operational…
- 50 Episodes in: Lessons from The Emerging Biotech Leader · 36 minPodcast hosts, Kim Kushner and Ramin Farhood celebrate the anniversary of The Emerging Biotech Leader, marking three years, 50 episodes, and listeners across 50 countries.








